1. Ackman says Allergan CEO has conflict of interest on takeover offer

    Ackman says Allergan CEO has conflict of interest on takeover offer

    Ackman and Montreal-based Valeant launched a $47 billion (27.9 billion pounds) takeover of the company on April 22, but Allergan rejected the offer on May 12 and has not budged since. Allergan Chief Executive Officer David Pyott is urging shareholders to let the company stand alone. Ackman, who controls a nearly 10 percent stake in Allergan as the head of Pershing Square Capital Management ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned